These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 23604282)

  • 1. Heterogeneity of tumor-induced gene expression changes in the human metabolic network.
    Hu J; Locasale JW; Bielas JH; O'Sullivan J; Sheahan K; Cantley LC; Vander Heiden MG; Vitkup D
    Nat Biotechnol; 2013 Jun; 31(6):522-9. PubMed ID: 23604282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer.
    Sciacovelli M; Frezza C
    FEBS J; 2017 Oct; 284(19):3132-3144. PubMed ID: 28444969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically-defined metabolic reprogramming in cancer.
    Mullen AR; DeBerardinis RJ
    Trends Endocrinol Metab; 2012 Nov; 23(11):552-9. PubMed ID: 22858391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cancer metabolism.
    Teicher BA; Linehan WM; Helman LJ
    Clin Cancer Res; 2012 Oct; 18(20):5537-45. PubMed ID: 23071355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The implications of IDH mutations for cancer development and therapy.
    Pirozzi CJ; Yan H
    Nat Rev Clin Oncol; 2021 Oct; 18(10):645-661. PubMed ID: 34131315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic alteration in tumorigenesis.
    Yang H; Xiong Y; Guan K
    Sci China Life Sci; 2013 Dec; 56(12):1067-75. PubMed ID: 24114443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2)-dependent Tup1 conversion (PIPTC) regulates metabolic reprogramming from glycolysis to gluconeogenesis.
    Han BK; Emr SD
    J Biol Chem; 2013 Jul; 288(28):20633-45. PubMed ID: 23733183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer metabolism: key players in metabolic reprogramming.
    Soga T
    Cancer Sci; 2013 Mar; 104(3):275-81. PubMed ID: 23279446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma.
    Khurshed M; Molenaar RJ; Lenting K; Leenders WP; van Noorden CJF
    Oncotarget; 2017 Jul; 8(30):49165-49177. PubMed ID: 28467784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking metabolic reprogramming to therapy resistance in cancer.
    Morandi A; Indraccolo S
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):1-6. PubMed ID: 28065746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic isoenzyme shifts in cancer as potential novel therapeutic targets.
    Ononye SN; Shi W; Wali VB; Aktas B; Jiang T; Hatzis C; Pusztai L
    Breast Cancer Res Treat; 2014 Dec; 148(3):477-88. PubMed ID: 25395317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycolytic genes in cancer cells are more than glucose metabolic regulators.
    Hu ZY; Xiao L; Bode AM; Dong Z; Cao Y
    J Mol Med (Berl); 2014 Aug; 92(8):837-45. PubMed ID: 24906457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion.
    Gladitz J; Klink B; Seifert M
    Acta Neuropathol Commun; 2018 Jun; 6(1):49. PubMed ID: 29890994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic alterations of cancer cells.
    Sciacovelli M; Gaude E; Hilvo M; Frezza C
    Methods Enzymol; 2014; 542():1-23. PubMed ID: 24862258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth.
    Gaglio D; Metallo CM; Gameiro PA; Hiller K; Danna LS; Balestrieri C; Alberghina L; Stephanopoulos G; Chiaradonna F
    Mol Syst Biol; 2011 Aug; 7():523. PubMed ID: 21847114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emerging Hallmarks of Cancer Metabolism.
    Pavlova NN; Thompson CB
    Cell Metab; 2016 Jan; 23(1):27-47. PubMed ID: 26771115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncometabolites: linking altered metabolism with cancer.
    Yang M; Soga T; Pollard PJ
    J Clin Invest; 2013 Sep; 123(9):3652-8. PubMed ID: 23999438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of metabolic genes and metabolites in cancer.
    Oermann EK; Wu J; Guan KL; Xiong Y
    Semin Cell Dev Biol; 2012 Jun; 23(4):370-80. PubMed ID: 22306135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive decoupling of metabolic genes in cancer.
    Reznik E; Sander C
    PLoS Comput Biol; 2015 May; 11(5):e1004176. PubMed ID: 25961905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.